Evidence map›Paper›PMID 34680528›Full record

ArticleBiomedicines2021

Longitudinal Pathogenic Properties and

Marie Petit, Marie-Laure Walet-Balieu, Damien Schapman, Marie-Laure Golinski, Carole Burel, Marion Barray, Laurent Drouot, Maud Maho-Vaillant, Vivien Hébert, Olivier Boyer and 3 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. IgGBiomedicines · 2022
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Marie PetitINSERM U1234, Normandie University, 76000 Rouen, France.ORCID 0000-0003-2187-3997
Marie-Laure Walet-BalieuEA4358, Laboratoire Glycobiologie et Matrice Extracellulaire Végétale (Glyco-MEV), Normandie University, 76821 Rouen, France.ORCID 0000-0002-1031-1916
Damien SchapmanPRIMACEN, Normandie University, 76821 Rouen, France.ORCID 0000-0002-8612-8536
Marie-Laure GolinskiINSERM U1234, Normandie University, 76000 Rouen, France.ORCID 0000-0002-3532-5345
Carole BurelEA4358, Laboratoire Glycobiologie et Matrice Extracellulaire Végétale (Glyco-MEV), Normandie University, 76821 Rouen, France.
Marion BarrayINSERM U1234, Normandie University, 76000 Rouen, France.
Laurent DrouotINSERM U1234, Normandie University, 76000 Rouen, France.ORCID 0000-0003-2879-9304
Maud Maho-VaillantINSERM U1234, Normandie University, 76000 Rouen, France.ORCID 0000-0003-4221-2792
Vivien HébertINSERM U1234, Normandie University, 76000 Rouen, France.ORCID 0000-0001-9071-2033
Olivier BoyerINSERM U1234, Normandie University, 76000 Rouen, France.ORCID 0000-0002-7591-307X
Muriel BardorEA4358, Laboratoire Glycobiologie et Matrice Extracellulaire Végétale (Glyco-MEV), Normandie University, 76821 Rouen, France.ORCID 0000-0002-0966-903X
Pascal JolyINSERM U1234, Normandie University, 76000 Rouen, France.
Sébastien CalboINSERM U1234, Normandie University, 76000 Rouen, France.ORCID 0000-0003-4358-8417
Inserm · FRNormandie Université · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pemphigus vulgaris is an autoimmune disease that occurs due to pathogenic autoantibodies that recognize the following epidermal adhesion proteins: desmogleins. Systemic corticosteroids usually decrease the titers of anti-desmoglein autoantibodies and improve patients' conditions. Since modifications of IgG

Indexed as

autoantibodiesglycanspathogenicpemphigus

Identifiers

PMID34680528
PMCPMC8533488
OpenAlexW3204276296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.